• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未经治疗的慢性精神分裂症患者对氟哌啶醇及癸酸氟哌啶醇的反应。

The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate.

作者信息

Leff J P, Tress K H

出版信息

Int Clin Psychopharmacol. 1986 Jul;1 Suppl 1:27-40.

PMID:3559160
Abstract

A group of 13 untreated schizophrenic patients was collected over two and a half years. They were prescribed a standard regime of oral haloperidol, and where possible were transferred to haloperidol decanoate depot injections when their clinical condition stabilised. The progress of their symptoms was monitored weekly with a modification of the Present State Examination called the PSE Change Rating Scale. The ratings demonstrated a surprisingly good response to neuroleptic treatment in these chronic patients. Ten out of the 13 reached an arbitrary criterion of improvement with respect to psychotic symptoms, and in six patients these disappeared entirely. The reasons why the patients remained untreated for so long are considered, and include vagrancy, living with high Expressed Emotion relatives, and neglect in the community.

摘要

在两年半的时间里收集了一组13名未经治疗的精神分裂症患者。他们被给予口服氟哌啶醇的标准治疗方案,并在临床状况稳定时尽可能转为氟哌啶醇癸酸酯长效注射剂治疗。使用一种名为PSE变化评定量表的改良版现况检查,每周监测他们症状的进展情况。评定结果显示,这些慢性患者对抗精神病药物治疗的反应出奇地好。13名患者中有10名在精神病症状方面达到了任意设定的改善标准,6名患者的症状完全消失。文中还探讨了这些患者长期未接受治疗的原因,包括流浪、与高情感表达亲属同住以及社区忽视等情况。

相似文献

1
The response of untreated chronic schizophrenics to haloperidol and haloperidol decanoate.未经治疗的慢性精神分裂症患者对氟哌啶醇及癸酸氟哌啶醇的反应。
Int Clin Psychopharmacol. 1986 Jul;1 Suppl 1:27-40.
2
Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.癸酸氟哌啶醇替代癸酸氟奋乃静进行精神分裂症及其他慢性精神病的维持治疗。
Acta Psychiatr Belg. 1982 Mar-Apr;82(2):216-23.
3
A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.氟哌啶醇癸酸酯与氟奋乃静癸酸酯治疗慢性精神分裂症患者的对照试验。
Int Clin Psychopharmacol. 1986 Jul;1 Suppl 1:15-23.
4
A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.一种将精神分裂症患者从口服氟哌啶醇治疗转换为长效氟哌啶醇治疗的实用负荷剂量方法。
J Clin Psychiatry. 1996 Jul;57(7):298-302.
5
Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
Int Clin Psychopharmacol. 1986 Jul;1 Suppl 1:1-11.
6
[Evaluation of clinical usefulness of decaldol (haloperidol decanoate) produced by WZF Polfa in Warsaw in long-term treatment of schizophrenia].
Psychiatr Pol. 1995 May-Jun;29(3):405-20.
7
[Chronic treatment of schizophrenia with injectable bromperidol decanoate].
Acta Psiquiatr Psicol Am Lat. 1985 Sep;31(3):222-8.
8
[Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
Psychiatr Prax. 1984 Mar;11(2):56-8.
9
Haloperidol decanoate in schizophreniform disorders. Clinical and neuroendocrine aspects.
Acta Psychiatr Belg. 1983 Jan-Feb;83(1):57-68.
10
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.临床药代动力学对精神分裂症患者抗精神病药物治疗的影响。
J Psychiatry Neurosci. 1994 Jul;19(4):254-64.